» Articles » PMID: 34396217

Aortic Stenosis and the Tyrosine Kinase Inhibitor Nilotinib In Chronic Myeloid Leukemia

Overview
Date 2021 Aug 16
PMID 34396217
Citations 3
Authors
Affiliations
Soon will be listed here.
Citing Articles

The two facets of receptor tyrosine kinase in cardiovascular calcification-can tyrosine kinase inhibitors benefit cardiovascular system?.

Masbuchin A, Widodo , Rohman M, Liu P Front Cardiovasc Med. 2022; 9:986570.

PMID: 36237897 PMC: 9552878. DOI: 10.3389/fcvm.2022.986570.


Differentiating pulmonary hypertension associated with protein kinase inhibitors.

Jacobs J, Jahangir E, Ryan J Pulm Circ. 2022; 12(2):e12075.

PMID: 35795494 PMC: 9248793. DOI: 10.1002/pul2.12075.


The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis.

Carracedo M, Pawelzik S, Artiach G, Pouwer M, Plunde O, Saliba-Gustafsson P Br J Pharmacol. 2022; 179(19):4709-4721.

PMID: 35751904 PMC: 9544120. DOI: 10.1111/bph.15911.

References
1.
Donnellan E, Masri A, Johnston D, Pettersson G, Rodriguez L, Popovic Z . Long-Term Outcomes of Patients With Mediastinal Radiation-Associated Severe Aortic Stenosis and Subsequent Surgical Aortic Valve Replacement: A Matched Cohort Study. J Am Heart Assoc. 2017; 6(5). PMC: 5524090. DOI: 10.1161/JAHA.116.005396. View

2.
Carracedo M, Artiach G, Witasp A, Claria J, Carlstrom M, Laguna-Fernandez A . The G-protein coupled receptor ChemR23 determines smooth muscle cell phenotypic switching to enhance high phosphate-induced vascular calcification. Cardiovasc Res. 2019; 115(10):1557-1566. DOI: 10.1093/cvr/cvy316. View

3.
Herrmann J, Yang E, Iliescu C, Cilingiroglu M, Charitakis K, Hakeem A . Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue. Circulation. 2016; 133(13):1272-89. PMC: 4817363. DOI: 10.1161/CIRCULATIONAHA.115.018347. View

4.
Baumgartner H, Hung J, Bermejo J, Chambers J, Edvardsen T, Goldstein S . Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017; 30(4):372-392. DOI: 10.1016/j.echo.2017.02.009. View

5.
Gomez-Stallons M, Wirrig-Schwendeman E, Hassel K, Conway S, Yutzey K . Bone Morphogenetic Protein Signaling Is Required for Aortic Valve Calcification. Arterioscler Thromb Vasc Biol. 2016; 36(7):1398-405. PMC: 4919184. DOI: 10.1161/ATVBAHA.116.307526. View